Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Patients' perspectives on palliative chemotherapy of colorectal and non--colorectal cancer: a prospective study in a chemotherapy- experienced population.

Mende M, Trautmann K, Rentsch A, Hornemann B, Schuler US, Ehninger G, Folprecht G.

BMC Cancer. 2013 Feb 7;13:66. doi: 10.1186/1471-2407-13-66.

3.

Palliative chemotherapy for advanced or metastatic colorectal cancer. Colorectal Meta-analysis Collaboration.

[No authors listed]

Cochrane Database Syst Rev. 2000;(2):CD001545. Review.

PMID:
10796809
4.

Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.

Tappenden P, Jones R, Paisley S, Carroll C.

Health Technol Assess. 2007 Mar;11(12):1-128, iii-iv. Review.

5.

Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.

Pentheroudakis G, Fountzilas G, Kalofonos HP, Golfinopoulos V, Aravantinos G, Bafaloukos D, Papakostas P, Pectasides D, Christodoulou C, Syrigos K, Economopoulos T, Pavlidis N; Hellenic Cooperative Oncology Group.

Crit Rev Oncol Hematol. 2008 Jun;66(3):237-47. doi: 10.1016/j.critrevonc.2007.12.003. Epub 2008 Feb 1.

PMID:
18243010
6.

Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer.

Glimelius B, Hoffman K, Graf W, Haglund U, Nyrén O, Påhlman L, Sjödén PO.

Ann Oncol. 1995 Mar;6(3):267-74.

PMID:
7542021
7.

Influence of palliative surgical resection on overall survival in patients with advanced colorectal cancer: a retrospective single institutional study.

Kaufman MS, Radhakrishnan N, Roy R, Gecelter G, Tsang J, Thomas A, Nissel-Horowitz S, Mehrotra B.

Colorectal Dis. 2008 Jun;10(5):498-502. Epub 2007 Oct 19.

PMID:
17949445
8.

The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy.

Tassinari D, Montanari L, Maltoni M, Ballardini M, Piancastelli A, Musi M, Porzio G, Minotti V, Caraceni A, Poggi B, Stella A, Aielli F, Scarpi E.

Support Care Cancer. 2008 Apr;16(4):359-70. Epub 2007 Jul 13.

PMID:
17629751
9.

Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).

Link K, Happich K, Schirner I, Jüngert B, Brückl V, Männlein G, Brückl WM, Merkel S, Göhl J, Hohenberger W, Hahn EG, Wein A.

Anticancer Res. 2004 Jan-Feb;24(1):385-91.

10.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
11.

Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older.

Popescu RA, Norman A, Ross PJ, Parikh B, Cunningham D.

J Clin Oncol. 1999 Aug;17(8):2412-8.

PMID:
10561304
12.

An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.

Pectasides D, Kalofonos HP, Samantas E, Nicolaides C, Papacostas P, Onyenadum A, Visvikis A, Skarlos D, Fountzilas G.

Anticancer Res. 2001 Jul-Aug;21(4B):3005-10.

PMID:
11712802
13.
14.

[Recent results of irinotecan therapy in colorectal cancer].

Láng I, Hitre E.

Magy Onkol. 2004;48(4):281-8. Epub 2005 Jan 17. Review. Hungarian.

15.

Early palliative intervention for patients with advanced cancer.

Otsuka M, Koyama A, Matsuoka H, Niki M, Makimura C, Sakamoto R, Sakai K, Fukuoka M.

Jpn J Clin Oncol. 2013 Aug;43(8):788-94. doi: 10.1093/jjco/hyt074. Epub 2013 Jun 4.

16.

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O'Rourke M, Levitan N, Gressot L, Vincent M, Burkes R, Coughlin S, Kim Y, Berille J.

J Clin Oncol. 2000 May;18(10):2095-103.

PMID:
10811675
17.
18.

Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice.

Koedoot CG, de Haan RJ, Stiggelbout AM, Stalmeier PF, de Graeff A, Bakker PJ, de Haes JC.

Br J Cancer. 2003 Dec 15;89(12):2219-26.

19.

[Chemotherapy of colorectal carcinoma].

Popov I, Jelić S, Radosavljević D, Nikolić-Tomasević Z.

Srp Arh Celok Lek. 1998 Nov-Dec;126(11-12):506-11. Review. Serbian.

PMID:
9921027
20.

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

Baselga J, Rischin D, Ranson M, Calvert H, Raymond E, Kieback DG, Kaye SB, Gianni L, Harris A, Bjork T, Averbuch SD, Feyereislova A, Swaisland H, Rojo F, Albanell J.

J Clin Oncol. 2002 Nov 1;20(21):4292-302.

PMID:
12409327
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk